Back to News
Market Impact: 0.35

Is SK Hynix Your Path to $1 Million by 2030?

+1
Technology & InnovationCredit & Bond MarketsCompany FundamentalsAnalyst InsightsCorporate Guidance & OutlookMarket Technicals & Flows
Is SK Hynix Your Path to $1 Million by 2030?

SK Hynix CEO says the DRAM memory shortage supporting record profits could last until at least 2030, but the article warns the market’s pricing momentum is already fading. TrendForce estimates Q3 DRAM prices rise 13%–18% vs ~60% in Q2, signaling an approaching earnings peak (analysts expect earnings to peak in 2027–2028) and risk of a sharp earnings/stock reset if supply ramps faster or demand hiccups. The stock is framed as trading around ~6x forward earnings (single-digit multiple), which the author argues is unlikely to sustain another ~500% upside without a new demand catalyst.

Analysis

The market is not paying for perpetual scarcity; it is paying for a late-cycle margin peak. In memory, the first derivative matters more than the absolute shortage: once the industry commits to new wafers and tool installs, pricing can decelerate fast while depreciation and start-up costs keep rising, so earnings often top out well before demand does. That makes the risk in SKHY and MU less about a collapse in end-demand and more about valuation compression as the street starts discounting the 2027/28 peak earlier.

The biggest second-order effect is competitive self-sabotage. Every major supplier has an incentive to add capacity while spreads are wide, which is rational individually but bearish collectively; it usually extends the cycle briefly and then worsens the trough. NVDA is not immune, but it has a different exposure: AI compute scarcity still supports mix and pricing, while memory makers are the ones most directly exposed to future ASP normalization. If hyperscalers or server OEMs work down inventory even modestly, the beta is highest in memory names, not in the AI accelerator complex.

Contrarian view: the consensus may be underestimating how quickly a "shortage through 2030" narrative loses power once investors see supply response and slowing ASP momentum. A move from explosive pricing to merely strong pricing is enough to trigger de-rating in cyclicals; the stock can fall 20-30% before fundamentals visibly break. The trade is better expressed as selling strength than chasing an overextended rerating, unless we get evidence that capex is being deferred rather than expanded.